Cargando…

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study

Detalles Bibliográficos
Autores principales:	Uutela, Aki, Nordin, Arno, Osterlund, Emerik, Halonen, Päivi, Kallio, Raija, Soveri, Leena-Maija, Salminen, Tapio, Ålgars, Annika, Ristimäki, Ari, Ovissi, Ali, Lamminmäki, Annamarja, Muhonen, Timo, Kononen, Juha, Ristamäki, Raija, Heervä, Eetu, Stedt, Hanna, Lehtomäki, Kaisa, Kytölä, Soili, Sundström, Jari, Mäkinen, Markus J, Nieminen, Lasse, Kuopio, Teijo, Keinänen, Mauri, Osterlund, Pia, Isoniemi, Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361677/ https://www.ncbi.nlm.nih.gov/pubmed/36511370 http://dx.doi.org/10.1093/bjs/znac424

Ejemplares similares

Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study
por: Uutela, Aki, et al.
Publicado: (2022)

Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)
por: Lehtomäki, Kaisa, et al.
Publicado: (2023)

Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study
por: Lehtomäki, Kaisa, et al.
Publicado: (2022)

KRAS-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer
por: Osterlund, Emerik, et al.
Publicado: (2022)

Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study
por: Osterlund, Pia, et al.
Publicado: (2021)

Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing
por: Holm, Matilda, et al.
Publicado: (2020)

Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study
por: Isoniemi, H, et al.
Publicado: (2021)

Heterogeneous EGFR Gene Copy Number Increase Is Common in Colorectal Cancer and Defines Response to Anti-EGFR Therapy
por: Ålgars, Annika, et al.
Publicado: (2014)

Short-course preoperative radiotherapy increases pelvic fracture risk in rectal cancer
por: Vesa, Väliaho, et al.
Publicado: (2023)

Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and (1)H-MR spectroscopy compared with histology (subgroup in the RAXO trial)
por: Uutela, A., et al.
Publicado: (2021)

A single-institution experience with bevacizumab in the treatment of metastatic colorectal cancer and in conjunction with liver resection
por: Osterlund, Pia, et al.
Publicado: (2014)

Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
por: Österlund, P, et al.
Publicado: (2011)

EGFR gene amplification is relatively common and associates with outcome in intestinal adenocarcinoma of the stomach, gastro-oesophageal junction and distal oesophagus
por: Birkman, Eva-Maria, et al.
Publicado: (2016)

Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer
por: Lehtomäki, Kaisa, et al.
Publicado: (2023)

Lung metastasectomy for colorectal cancer in the PulMiCC randomised controlled trial – Authors’ reply
por: Osterlund, Pia, et al.
Publicado: (2021)

Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases
por: Peltonen, Reetta, et al.
Publicado: (2020)

Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics
por: Birkman, Eva-Maria, et al.
Publicado: (2017)

Association of tumor-infiltrating T lymphocytes with intestinal-type gastric cancer molecular subtypes and outcome
por: Mansuri, Naziha, et al.
Publicado: (2020)

FHOD1 and FMNL1 formin proteins in intestinal gastric cancer: correlation with tumor-infiltrating T lymphocytes and molecular subtypes
por: Mansuri, Naziha, et al.
Publicado: (2021)

Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than before, But How High Is It?
por: Osterman, Erik, et al.
Publicado: (2020)

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study
por: Osterlund, P., et al.
Publicado: (2022)

Detection of microsatellite instability with Idylla MSI assay in colorectal and endometrial cancer
por: Ukkola, Iiris, et al.
Publicado: (2021)

Sex differences in metastatic surgery following diagnosis of synchronous metastatic colorectal cancer
por: Ljunggren, Malin, et al.
Publicado: (2022)

Association between Computed Tomography-Determined Loss of Muscle Mass and Impaired Three-Month Survival in Frail Older Adults with Cancer
por: Tolonen, Antti, et al.
Publicado: (2023)

Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer
por: Lehtomäki, Kaisa, et al.
Publicado: (2021)

Helicobacter pylori and gastrointestinal symptoms in diagnostics and adjuvant chemotherapy of colorectal cancer
por: SOVERI, LEENA-MAIJA, et al.
Publicado: (2014)

Impact of deep learning-determined smoking status on mortality of cancer patients: never too late to quit
por: Karlsson, A., et al.
Publicado: (2021)

N-Glycomic Profiling of Microsatellite Unstable Colorectal Cancer
por: Ukkola, Iiris, et al.
Publicado: (2023)

EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer
por: Ålgars, A, et al.
Publicado: (2011)

Reply: EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
por: Ålgars, A, et al.
Publicado: (2012)

Gene fusions and oncogenic mutations in MLH1 deficient and BRAFV600E wild-type colorectal cancers
por: Ukkola, Iiris, et al.
Publicado: (2022)

Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma
por: Mäkelä, Rami, et al.
Publicado: (2020)

Influence of Sampling Practices on the Appearance of DNA Image Histograms of Prostate Cells in FNAB Samples
por: Buhmeida, Abdelbaset, et al.
Publicado: (1999)

Ex vivo assessment of targeted therapies in a rare metastatic epithelial–myoepithelial carcinoma
por: Mäkelä, Rami, et al.
Publicado: (2020)

Clonal dynamics using droplet digital polymerase chain reaction in peripheral blood predicts treatment responses in myelodysplastic syndrome
por: Illman, Johanna, et al.
Publicado: (2022)

Ex Vivo Drug Screening Informed Targeted Therapy for Metastatic Parotid Squamous Cell Carcinoma
por: Nykänen, Noora, et al.
Publicado: (2021)

Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma
por: MATTILA, Kalle, et al.
Publicado: (2023)

Cardiovascular disease risk and all-cause mortality associated with accelerometer-measured physical activity and sedentary time ‒ a prospective population-based study in older adults
por: Länsitie, Miia, et al.
Publicado: (2022)

Factors associated with parental recognition of a child's overweight status - a cross sectional study
por: Vanhala, Marja L, et al.
Publicado: (2011)

The Reproducibility of Nuclear Morphometric Measurements in Invasive Breast Carcinoma
por: Kronqvist, Pauliina, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_1j0un7hbnkspff1eigtovifpm0